Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02579161 · ClinicalTrials.gov registry record · Phase 3
Trial of Randomized Antibiotic Administration in Percutaneous Nephrolithotomy
A Phase 3 study, sponsored by Northwell Health.
- Completed
- Registry status
- Phase 3
- Development phase
- 98
- Enrollment target
NCT02579161 is a Phase 3 study that has completed, run by Northwell Health. The registered enrollment target is 98 participants.
The verdict
NCT02579161, a Phase 3 study, has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 98 participants
- Enrollment target
Study Summary
The Investigators objective is to compare the clinical efficacy of a single-day protocol with a short-course protocol for PCNL. The investigator hope is to reduce the use of possibly unnecessary prolonged antibiotic use, reduce hospital costs and prevent the further propagation of resistant microbes.
Interventions
- DRUG Clindamycin
- DRUG cephalosporins
- DRUG Fluoroquinolones
- DRUG Ampicillin/Gentamicin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2014-09 |
| Est. Completion | 2018-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02579161
The ClinicalTrials.gov registry entry for NCT02579161 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 98 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Clindamycin is the first listed.
NCT02579161 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02579161 about?
NCT02579161 is a clinical study titled "Trial of Randomized Antibiotic Administration in Percutaneous Nephrolithotomy". The Investigators objective is to compare the clinical efficacy of a single-day protocol with a short-course protocol for PCNL. The investigator hope is to reduce the use of possibly unnecessary prolonged antibiotic use, reduce hospital costs and prevent the further propagation of resistant microbes...
What is the current status of trial NCT02579161?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 98 participants. The study started on 2014-09. Estimated completion is 2018-12.
What interventions are being tested in trial NCT02579161?
The interventions under investigation include: Clindamycin (DRUG), cephalosporins (DRUG), Fluoroquinolones (DRUG), Ampicillin/Gentamicin (DRUG).
Who is sponsoring clinical trial NCT02579161?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.